USP <51> - Antimicrobial Effectiveness Testing

What it says

Multi-dose and certain other aqueous-based formulations must be tested to demonstrate that their antimicrobial preservative system effectively reduces or maintains microbial challenge organisms within defined limits over a specified time period, confirming the preservative system is adequate for the product's intended use.

Paraphrased for plain-language clarity. Always verify against the current published regulation text.

What it means in practice

• Antimicrobial effectiveness testing is not the same as sterility testing, it specifically evaluates whether the preservative system in a non-sterile or multi-dose product can control contamination introduced during normal use.
• A formulation change, even one that seems unrelated to preservative content, such as a change in pH, viscosity or a different excipient, can affect preservative effectiveness and may require retesting.
• This testing is particularly critical for multi-dose containers that are opened and used repeatedly by patients, where the container's closure integrity alone cannot prevent microbial ingress.

What inspectors look for

• Whether antimicrobial effectiveness testing was performed on the actual marketed formulation and container-closure system, not just an early development formulation.
• Whether formulation or process changes that could plausibly affect preservative effectiveness were evaluated for a need to retest.
• Whether the challenge organisms and acceptance criteria used match what the applicable USP category requires for that product type.

Related regulations